Zobrazeno 1 - 10
of 630
pro vyhledávání: '"D, Pickar"'
Autor:
D. Pickar
Publikováno v:
JAMA: The Journal of the American Medical Association. 274:981-983
Autor:
Ronald F. Levant, Judith E. N. Albino, Anita B. Brown, Samuel A. Feldman, Raymond A. Folen, Peggy Kaczmarek, Elaine S. LeVine, Robert E. McGrath, Gloria D. Pickar, A. Eugene Shapiro, Steven R. Tulkin, Cal VanderPlate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d47242f393947aeed85700552f47f08
https://doi.org/10.1037/10484-007
https://doi.org/10.1037/10484-007
Publikováno v:
Psychopharmacology bulletin. 34(3)
This article presents two algorithms dealing with the management of schizophrenia. One provides a strategy for initiating pharmacologic treatment of schizophrenia and for ongoing medication management. The other covers suggestions for managing severa
Autor:
D L, Murphy, F, Karoum, D, Pickar, R M, Cohen, S, Lipper, A M, Mellow, P N, Tariot, T, Sunderland
Publikováno v:
Journal of neural transmission. Supplementum. 52
Marked, dose-dependent elevations in the urinary excretion of phenylethylamine, para-tyramine, and meta-tyramine were observed in depressed patients treated for three or more weeks with 10, 30, or 60 mg/day of the partially-selective inhibitor of MAO
Publikováno v:
Synapse (New York, N.Y.). 29(2)
Agents that antagonize the glutamatergic N-methyl-d-aspartate (NMDA) receptor, such as phenylcyclidine (PCP) and ketamine, produce a behavioral state in healthy volunteers that resembles some aspects of schizophrenia. A dysfunction in NMDA-dopaminerg
Publikováno v:
Lancet (London, England). 347(9018)
Autor:
D. Pickar
Publikováno v:
Lancet (London, England). 345(8949)
Publikováno v:
Psychopharmacology bulletin. 31(3)
Publikováno v:
Psychopharmacology bulletin. 31(1)
Natural products have a long history of being the sources for therapeutic drugs in medicine. Investigations of natural products also have the potential for enhancing our understanding about the pathophysiology and treatment of various disorders. The
Publikováno v:
The Journal of clinical psychiatry. 55
The introduction of the atypical neuroleptic, clozapine, has had widespread influence not only on the treatment of the seriously mentally ill patient, but also on new drug development and on hypotheses of the pathophysiology of schizophrenia. While c